Real-time enrollment status for this seizures clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:30 AM UTC
| NCT Number | NCT05667142 |
| Recruiting Status | Recruiting |
| Condition | Seizures |
| Phase | PHASE3 |
| Target Enrollment | 160 participants |
| Active Locations | 59 sites in the US |
| Sponsor | Xenon Pharmaceuticals Inc. |
| Last Updated on CT.gov | July 8, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT05667142 is currently recruiting participants. This phase3 study for seizures is actively seeking new participants at 59 locations across the United States. The study is sponsored by Xenon Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05667142 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 59 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05667142 was last updated 1 week ago (July 8, 2026). HelloStudys verifies this status automatically.